Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection

References

• Schackman BR, Fleishman JA, Su AE, Berkowitz BK, Moore RD, Walensky RP, Becker JE, Voss C, Paltiel AD, Weinstein MC, et al. The Lifetime Medical Cost Savings from Preventing HIV in the United States. Med Care. 2015;53:293-301. PMID:25710311.
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-71. doi:10.1038/nm1511. PMID:17115046.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, et al. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. The Lancet. 2012;380:1250-8. doi:10.1016/S0140-6736(12)61038-1.
   PubMed Web of Science ®Google Scholar
• Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387:183-8. doi:10.1038/387183a0. PMID:9144289.
   PubMed Web of Science ®Google Scholar
• Butler KM, Gavin P, Coughlan S, Rochford A, Donagh SM, Cunningham O, Poulsom H, Watters S, Klein N. Rapid Viral Rebound after 4 Years of Suppressive Therapy in a Seronegative HIV-1 Infected Infant Treated from Birth. Pediatr Infect Dis J. 2014; PMID:25144802.
   PubMed Web of Science ®Google Scholar
• Calza L. Renal toxicity associated with antiretroviral therapy. HIV Clin Trials. 2012;13:189-211. doi:10.1310/hct1304-189. PMID:22849961.
   PubMed Web of Science ®Google Scholar
• Chun T-W, Nickle DC, Justement JS, Meyers JH, Roby G, Hallahan CW, Kottilil S, Moir S, Mican JM, Mullins JI, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis. 2008;197:714-20. doi:10.1086/527324. PMID:18260759.
   PubMed Web of Science ®Google Scholar
• Crooks AM, Bateson R, Cope AB, Dahl NP, Griggs MK, Kuruc JD, Gay CL, Eron JJ, Margolis DM, Bosch RJ, et al. Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. J Infect Dis. 2015;212:1361-5. doi:10.1093/infdis/jiv218. PMID:25877550.
   PubMed Web of Science ®Google Scholar
• Mylvaganam GH, Silvestri G, Amara RR. HIV therapeutic vaccines: moving towards a functional cure. Curr Opin Immunol. 2015;35:1-8. doi:10.1016/j.coi.2015.05.001. PMID:25996629.
   PubMed Web of Science ®Google Scholar
• de Mendoza C, Barreiro P, Benitez L, Soriano V. Gene therapy for HIV infection. Expert Opin Biol Ther. 2015;15:319-27. doi:10.1517/14712598.2015.967208. PMID:25323559.
   PubMed Web of Science ®Google Scholar
• García F, Plana M, Climent N, León A, Gatell JM, Gallart T. Dendritic cell based vaccines for HIV infection: the way ahead. Hum Vaccines Immunother. 2013;9:2445-52. doi:10.4161/hv.25876.
   PubMed Web of Science ®Google Scholar
• Rasmussen TA, Tolstrup M, Søgaard OS. Reversal of Latency as Part of a Cure for HIV-1. Trends Microbiol. 2016;24:90-7. doi:10.1016/j.tim.2015.11.003. PMID:26690612.
   PubMed Web of Science ®Google Scholar
• von Gegerfelt AS, Rosati M, Alicea C, Valentin A, Roth P, Bear J, Franchini G, Albert PS, Bischofberger N, Boyer JD, et al. Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization. J Virol. 2007;81:1972-9. doi:10.1128/JVI.01990-06. PMID:17135321.
   PubMed Web of Science ®Google Scholar
• Halwani R, Boyer JD, Yassine-Diab B, Haddad EK, Robinson TM, Kumar S, Parkinson R, Wu L, Sidhu MK, Phillipson-Weiner R, et al. Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques. J Immunol Baltim Md 1950. 2008;180:7969-79.
   Google Scholar
• Valentin A, von Gegerfelt A, Rosati M, Miteloudis G, Alicea C, Bergamaschi C, Jalah R, Patel V, Khan AS, Draghia-Akli R, et al. Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit. Vaccine. 2010;28:1962-74. doi:10.1016/j.vaccine.2009.10.099. PMID:20188252.
   PubMed Web of Science ®Google Scholar
• Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999;283:857-60. doi:10.1126/science.283.5403.857. PMID:9933172.
   PubMed Web of Science ®Google Scholar
• Mothe B, Llano A, Ibarrondo J, Zamarreño J, Schiaulini M, Miranda C, Ruiz-Riol M, Berger CT, Herrero MJ, Palou E, et al. CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control. PLoS ONE. 2012;7:e29717. doi:10.1371/journal.pone.0029717. PMID:22238642.
   PubMed Web of Science ®Google Scholar
• Rolland M, Heckerman D, Deng W, Rousseau CM, Coovadia H, Bishop K, Goulder PJR, Walker BD, Brander C, Mullins JI. Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads. PLoS ONE. 2008;3:e1424. doi:10.1371/journal.pone.0001424. PMID:18183304.
   PubMed Web of Science ®Google Scholar
• Tubiana R, Carcelain G, Vray M, Gourlain K, Dalban C, Chermak A, Rabian C, Vittecoq D, Simon A, Bouvet E, et al. Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094). Vaccine. 2005;23:4292-301. doi:10.1016/j.vaccine.2005.04.013. PMID:15927325.
   PubMed Web of Science ®Google Scholar
• De Rose R, Fernandez CS, Smith MZ, Batten CJ, Alcântara S, Peut V, Rollman E, Loh L, Mason RD, Wilson K, et al. Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood. PLoS Pathog. 2008;4:e1000055. doi:10.1371/journal.ppat.1000055. PMID:18451982.
   PubMed Web of Science ®Google Scholar
• Hel Z, Venzon D, Poudyal M, Tsai WP, Giuliani L, Woodward R, Chougnet C, Shearer G, Altman JD, Watkins D, et al. Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques. Nat Med. 2000;6:1140-6. doi:10.1038/80481. PMID:11017146.
   PubMed Web of Science ®Google Scholar
• Pollard RB, Rockstroh JK, Pantaleo G, Asmuth DM, Peters B, Lazzarin A, Garcia F, Ellefsen K, Podzamczer D, van Lunzen J, et al. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2014;14:291-300. doi:10.1016/S1473-3099(13)70343-8. PMID:24525316.
   PubMed Web of Science ®Google Scholar
• Fuller DH, Rajakumar P, Che JW, Narendran A, Nyaundi J, Michael H, Yager EJ, Stagnar C, Wahlberg B, Taber R, et al. Therapeutic DNA Vaccine Induces Broad T Cell Responses in the Gut and Sustained Protection from Viral Rebound and AIDS in SIV-Infected Rhesus Macaques. PLoS ONE. 2012; 7:e33715. doi:10.1371/journal.pone.0033715. PMID:22442716.
   PubMed Web of Science ®Google Scholar
• Liu Y, McNevin J, Rolland M, Zhao H, Deng W, Maenza J, Stevens CE, Collier AC, McElrath MJ, Mullins JI. Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses. J Infect Dis. 2009;200:1825-33. doi:10.1086/648401. PMID:19909083.
   PubMed Web of Science ®Google Scholar
• Li F, Finnefrock AC, Dubey SA, Korber BTM, Szinger J, Cole S, McElrath MJ, Shiver JW, Casimiro DR, Corey L, et al. Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study. PloS One. 2011;6:e20479. doi:10.1371/journal.pone.0020479. PMID:21695251.
   PubMed Web of Science ®Google Scholar
• Deng K, Pertea M, Rongvaux A, Wang L, Durand CM, Ghiaur G, Lai J, McHugh HL, Hao H, Zhang H, et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature. 2015;517:381-5. doi:10.1038/nature14053. PMID:25561180.
   PubMed Web of Science ®Google Scholar
• Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, et al. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med. 2011;17:366-71. doi:10.1038/nm.2316. PMID:21358627.
   PubMed Web of Science ®Google Scholar
• Herbeck JT, Rolland M, Liu Y, McLaughlin S, McNevin J, Zhao H, Wong K, Stoddard JN, Raugi D, Sorensen S, et al. Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J Virol. 2011;85:7523-34. doi:10.1128/JVI.02697-10. PMID:21593162.
   PubMed Web of Science ®Google Scholar
• Kulkarni V, Rosati M, Valentin A, Ganneru B, Singh AK, Yan J, Rolland M, Alicea C, Beach RK, Zhang G-M, et al. HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice. PloS One. 2013;8:e60245. doi:10.1371/journal.pone.0060245. PMID:23555935.
   PubMed Web of Science ®Google Scholar
• Kulkarni V, Valentin A, Rosati M, Alicea C, Singh AK, Jalah R, Broderick KE, Sardesai NY, Le Gall S, Mothe B, et al. Altered Response Hierarchy and Increased T-Cell Breadth upon HIV-1 Conserved Element DNA Vaccination in Macaques. PloS One. 2014;9:e86254. doi:10.1371/journal.pone.0086254. PMID:24465991.
   PubMed Web of Science ®Google Scholar
• Kulkarni V, Valentin A, Rosati M, Rolland M, Mullins JI, Pavlakis GN, Felber BK. HIV-1 Conserved Elements p24CE DNA Vaccine Induces Humoral Immune Responses with Broad Epitope Recognition in Macaques. PLOS ONE. 2014;9:e111085. doi:10.1371/journal.pone.0111085. PMID:25338098.
   PubMed Web of Science ®Google Scholar
• Hu X, Valentin A, Dayton F, Kulkarni V, Alicea C, Rosati M, Chowdhury B, Gautam R, Broderick KE, Sardesai NY, et al. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. J Immunol. 2016;1600697.
   Web of Science ®Google Scholar
• Kunwar P, Hawkins N, Dinges WL, Liu Y, Gabriel EE, Swan DA, Stevens CE, Maenza J, Collier AC, Mullins JI, et al. Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design. PloS One. 2013;8:e64405. doi:10.1371/journal.pone.0064405. PMID:23741326.
   PubMed Web of Science ®Google Scholar
• Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C, Mncube Z, Mkhwanazi N, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007; 13:46-53. doi:10.1038/nm1520. PMID:17173051.
   PubMed Web of Science ®Google Scholar
• Zuñiga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, Sanchez H, Frahm N, Linde CH, Hewitt HS, et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol. 2006;80:3122-5. doi:10.1128/JVI.80.6.3122-3125.2006. PMID:16501126.
   PubMed Web of Science ®Google Scholar
• Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A. 2000;97:2709-14. doi:10.1073/pnas.050567397. PMID:10694578.
   PubMed Web of Science ®Google Scholar
• Streeck H, Lichterfeld M, Alter G, Meier A, Teigen N, Yassine-Diab B, Sidhu HK, Little S, Kelleher A, Routy J-P, et al. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol. 2007;81:7725-31. doi:10.1128/JVI.00708-07. PMID:17494064.
   PubMed Web of Science ®Google Scholar
• Schneidewind A, Brockman MA, Sidney J, Wang YE, Chen H, Suscovich TJ, Li B, Adam RI, Allgaier RL, Mothé BR, et al. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J Virol. 2008;82:5594-605. doi:10.1128/JVI.02356-07. PMID:18385228.
   PubMed Web of Science ®Google Scholar
• Dinges WL, Richardt J, Friedrich D, Jalbert E, Liu Y, Stevens CE, Maenza J, Collier AC, Geraghty DE, Smith J, et al. Virus-Specific CD8+ T-Cell Responses Better Define HIV Disease Progression than HLA Genotype. J Virol. 2010;84:4461-8. doi:10.1128/JVI.02438-09. PMID:20147397.
   PubMed Web of Science ®Google Scholar
• Leitman EM, Willberg CB, De Burgh-Thomas A, Streeck H, Goulder PJR, Matthews PC. Subdominant Gag-specific anti-HIV efficacy in an HLA-B∗57-positive elite controller. AIDS Lond Engl. 2016;30:972-4. doi:10.1097/QAD.0000000000001022.
   PubMed Web of Science ®Google Scholar
• Friedrich TC, Valentine LE, Yant LJ, Rakasz EG, Piaskowski SM, Furlott JR, Weisgrau KL, Burwitz B, May GE, León EJ, et al. Subdominant CD8+ T-Cell Responses Are Involved in Durable Control of AIDS Virus Replication. J Virol. 2007;81:3465-76. doi:10.1128/JVI.02392-06. PMID:17251286.
   PubMed Web of Science ®Google Scholar
• Frahm N, Kiepiela P, Adams S, Linde CH, Hewitt HS, Sango K, Feeney ME, Addo MM, Lichterfeld M, Lahaie MP, et al. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol. 2006;7:173-8. doi:10.1038/ni1281. PMID:16369537.
   PubMed Web of Science ®Google Scholar
• Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, Kadie CM, Carlson JM, Markle TJ, Streeck H, et al. Early Selection in Gag by Protective HLA Alleles Contributes to Reduced HIV-1 Replication Capacity That May Be Largely Compensated for in Chronic Infection. J Virol. 2010;84:11937-49. doi:10.1128/JVI.01086-10. PMID:20810731.
   PubMed Web of Science ®Google Scholar
• Demberg T, Florese RH, Heath MJ, Larsen K, Kalisz I, Kalyanaraman VS, Lee EM, Pal R, Venzon D, Grant R, et al. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol. 2007;81:3414-27. doi:10.1128/JVI.02453-06. PMID:17229693.
   PubMed Web of Science ®Google Scholar
• Zhao J, Voltan R, Peng B, Davis-Warren A, Kalyanaraman VS, Alvord WG, Aldrich K, Bernasconi D, Buttò S, Cafaro A, et al. Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. Virology. 2005;342:1-12. doi:10.1016/j.virol.2005.07.016. PMID:16109434.
   PubMed Web of Science ®Google Scholar
• Zhao J, Lou Y, Pinczewski J, Malkevitch N, Aldrich K, Kalyanaraman VS, Venzon D, Peng B, Patterson LJ, Edghill-Smith Y, et al. Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants. Vaccine. 2003;21:4022-35. doi:10.1016/S0264-410X(03)00266-4. PMID:12922139.
   PubMed Web of Science ®Google Scholar
• Patterson LJ, Malkevitch N, Pinczewski J, Venzon D, Lou Y, Peng B, Munch C, Leonard M, Richardson E, Aldrich K, et al. Potent, Persistent Induction and Modulation of Cellular Immune Responses in Rhesus Macaques Primed with Ad5hr-Simian Immunodeficiency Virus (SIV) env/rev, gag, and/or nef Vaccines and Boosted with SIV gp120. J Virol. 2003;77:8607-20. doi:10.1128/JVI.77.16.8607-8620.2003. PMID:12885879.
   PubMed Web of Science ®Google Scholar
• Yant LJ, Friedrich TC, Johnson RC, May GE, Maness NJ, Enz AM, Lifson JD, O'Connor DH, Carrington M, Watkins DI. The high-frequency major histocompatibility complex class I Allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol. 2006;80:5074-7. doi:10.1128/JVI.80.10.5074-5077.2006. PMID:16641299.
   PubMed Web of Science ®Google Scholar
• Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, Beal DR, Wilson NA, Rehrauer WM, et al. Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication. J Virol. 2007;81:8827-32. doi:10.1128/JVI.00895-07. PMID:17537848.
   PubMed Web of Science ®Google Scholar
• Giraldo-Vela JP, Rudersdorf R, Chung C, Qi Y, Wallace LT, Bimber B, Borchardt GJ, Fisk DL, Glidden CE, Loffredo JT, et al. The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers. J Virol. 2008;82:859-70. doi:10.1128/JVI.01816-07. PMID:17989178.
   PubMed Web of Science ®Google Scholar
• Le Gall S, Stamegna P, Walker BD. Portable flanking sequences modulate CTL epitope processing. J Clin Invest. 2007;117:3563-75. doi:10.1172/JCI32047. PMID:17975674.
   PubMed Web of Science ®Google Scholar
• Zhang SC, Martin E, Shimada M, Godfrey SB, Fricke J, Locastro S, Lai NY, Liebesny P, Carlson JM, Brumme CJ, et al. Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals. J Immunol Baltim Md 1950. 2012;188:5924-34.
   Google Scholar
• Rolland M, Nickle DC, Mullins JI. HIV-1 group M conserved elements vaccine. PLoS Pathog. 2007;3:e157. doi:10.1371/journal.ppat.0030157. PMID:18052528.
   PubMed Web of Science ®Google Scholar
• Mankowski JL, Flaherty MT, Spelman JP, Hauer DA, Didier PJ, Amedee AM, Murphey-Corb M, Kirstein LM, Muñoz A, Clements JE, et al. Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol. 1997;71:6055-60. PMID:9223498.
   PubMed Web of Science ®Google Scholar
• Reimann KA, Li JT, Veazey R, Halloran M, Park IW, Karlsson GB, Sodroski J, Letvin NL. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol. 1996;70:6922-8. PMID:8794335.
   PubMed Web of Science ®Google Scholar
• Arrington J, Braun RP, Dong L, Fuller DH, Macklin MD, Umlauf SW, Wagner SJ, Wu MS, Payne LG, Haynes JR. Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin from Escherichia coli Are Strong Adjuvants for DNA Vaccines. J Virol. 2002;76:4536-46. doi:10.1128/JVI.76.9.4536-4546.2002. PMID:11932419.
   PubMed Web of Science ®Google Scholar
• Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol. 1997;71:5790-8. PMID:9223467.
   PubMed Web of Science ®Google Scholar
• Ling B, Mohan M, Lackner AA, Green LC, Marx PA, Doyle LA, Veazey RS. The Large Intestine as a Major Reservoir for Simian Immunodeficiency Virus in Macaques with Long-Term, Nonprogressing Infection. J Infect Dis. 2010; 202:1846-54. doi:10.1086/657413. PMID:21050120.
   PubMed Web of Science ®Google Scholar
• Fukazawa Y, Park H, Cameron MJ, Lefebvre F, Lum R, Coombes N, Mahyari E, Hagen SI, Bae JY, Reyes MD 3rd, et al. Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nat Med. 2012;18:1673-81. doi:10.1038/nm.2934. PMID:22961108.
   PubMed Web of Science ®Google Scholar
• Freel SA, Lamoreaux L, Chattopadhyay PK, Saunders K, Zarkowsky D, Overman RG, Ochsenbauer C, Edmonds TG, Kappes JC, Cunningham CK, et al. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. J Virol. 2010;84:4998-5006. doi:10.1128/JVI.00138-10. PMID:20200250.
   PubMed Web of Science ®Google Scholar
• Betts MR, Nason MC, West SM, Rosa SCD, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107:4781-9. doi:10.1182/blood-2005-12-4818. PMID:16467198.
   PubMed Web of Science ®Google Scholar
• Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, Kovacs CM, Rodriguez B, Sieg SF, Teixeira-Johnson L, et al. Perforin expression directly ex vivo by HIV-specific CD8+ T-cells is a correlate of HIV elite control. PLoS Pathog. 2010;6:e1000917. doi:10.1371/journal.ppat.1000917. PMID:20523897.
   PubMed Web of Science ®Google Scholar
• Trichel AM, Rajakumar PA, Murphey-Corb M. Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol. 2002;31:171-8. doi:10.1034/j.1600-0684.2002.02003.x. PMID:12390539.
   PubMed Web of Science ®Google Scholar
• Geldmacher C, Gray C, Nason M, Currier JR, Haule A, Njovu L, Geis S, Hoffmann O, Maboko L, Meyerhans A, et al. A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infection. J Virol. 2007;81:13809-15. doi:10.1128/JVI.01566-07. PMID:17898052.
   PubMed Web of Science ®Google Scholar
• Osuna CE, Gonzalez AM, Chang H-H, Hung AS, Ehlinger E, Anasti K, Alam SM, Letvin NL. TCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in mamu-A*01+ rhesus monkeys. PLOS Pathog. 2014;10:e1004069. doi:10.1371/journal.ppat.1004069. PMID:24743648.
   PubMed Web of Science ®Google Scholar
• Conrad JA, Ramalingam RK, Smith RM, Barnett L, Lorey SL, Wei J, Simons BC, Sadagopal S, Meyer-Olson D, Kalams SA. Dominant clonotypes within HIV-specific T cell responses are programmed death-1high and CD127low and display reduced variant cross-reactivity. J Immunol Baltim Md 1950. 2011;186:6871-85.
   Google Scholar
• Stephenson KE, SanMiguel A, Simmons NL, Smith K, Lewis MG, Szinger JJ, Korber B, Barouch DH. Full-Length HIV-1 Immunogens Induce Greater Magnitude and Comparable Breadth of T Lymphocyte Responses to Conserved HIV-1 Regions Compared with Conserved-Region-Only HIV-1 Immunogens in Rhesus Monkeys. J Virol. 2012;86:11434-40. doi:10.1128/JVI.01779-12. PMID:22896617.
   PubMed Web of Science ®Google Scholar
• Schirmbeck R, Reimann J, Kochanek S, Kreppel F. The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens. Mol Ther J Am Soc Gene Ther. 2008;16:1609-16. doi:10.1038/mt.2008.141.
   PubMed Web of Science ®Google Scholar
• Horiike M, Iwami S, Kodama M, Sato A, Watanabe Y, Yasui M, Ishida Y, Kobayashi T, Miura T, Igarashi T. Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy. Virology. 2012;423:107-18. doi:10.1016/j.virol.2011.11.024. PMID:22196013.
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Hel Z, Kelsall B, Kuznetsov VA, Ahlers JD, Nacsa J, Watkins DI, Allen TM, Sette A, Altman J, et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med. 2001;7:1320-6. doi:10.1038/nm1201-1320. PMID:11726972.
   PubMed Web of Science ®Google Scholar
• Rothenberger MK, Keele BF, Wietgrefe SW, Fletcher CV, Beilman GJ, Chipman JG, Khoruts A, Estes JD, Anderson J, Callisto SP, et al. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption. Proc Natl Acad Sci U S A. 2015;112:E1126-1134. doi:10.1073/pnas.1414926112. PMID:25713386.
   PubMed Web of Science ®Google Scholar
• Mankowski JL, Flaherty MT, Spelman JP, Hauer DA, Didier PJ, Amedee AM, Murphey-Corb M, Kirstein LM, Muñoz A, Clements JE, et al. Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol. 1997;71:6055-60. PMID:9223498.
   PubMed Web of Science ®Google Scholar